{"identifier":"/us/usc/t21/s356e","title_num":"21","num":"§ 356e.","heading":"Drug shortage list","status":null,"guid":"id1a66db09-496b-11ed-a249-ef13b15378ec","source_credit":"(June 25, 1938, ch. 675, § 506E, as added Pub. L. 112–144, title X, § 1004, July 9, 2012, 126 Stat. 1104; amended Pub. L. 114–255, div. A, title III, § 3101(a)(2)(G), Dec. 13, 2016, 130 Stat. 1153; Pub. L. 116–136, div. A, title III, § 3112(c), Mar. 27, 2020, 134 Stat. 362.)","seq_in_title":171,"parent_identifier":"/us/usc/t21/ch9/schV/ptA","ancestors":[{"identifier":"/us/usc/t21","level":"title","num":"Title 21—","heading":"FOOD AND DRUGS","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch9","level":"chapter","num":"CHAPTER 9—","heading":"FEDERAL FOOD, DRUG, AND COSMETIC ACT","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch9/schV","level":"subchapter","num":"SUBCHAPTER V—","heading":"DRUGS AND DEVICES","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch9/schV/ptA","level":"part","num":"Part A—","heading":"Drugs and Devices","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"id7d08426b-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e\"><num value=\"356e\">§ 356e.</num><heading> Drug shortage list</heading><subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7d08426c-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/a\"><num value=\"a\" class=\"bold\">(a)</num><heading class=\"bold\"> Establishment</heading><content><p style=\"-uslm-lc:I11\" class=\"indent0\">The Secretary shall maintain an up-to-date list of drugs that are determined by the Secretary to be in shortage in the United States.</p>\n</content>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7d08426d-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b\"><num value=\"b\" class=\"bold\">(b)</num><heading class=\"bold\"> Contents</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">For each drug on such list, the Secretary shall include the following information:</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7d08697e-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/1\"><num value=\"1\">(1)</num><content> The name of the drug in shortage, including the National Drug Code number for such drug.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7d08697f-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/2\"><num value=\"2\">(2)</num><content> The name of each manufacturer of such drug.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7d086980-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3\"><num value=\"3\">(3)</num><chapeau> The reason for the shortage, as determined by the Secretary, selecting from the following categories:</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086981-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/A\"><num value=\"A\">(A)</num><content> Requirements related to complying with good manufacturing practices.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086982-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/B\"><num value=\"B\">(B)</num><content> Regulatory delay.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086983-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/C\"><num value=\"C\">(C)</num><content> Shortage of an active ingredient.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086984-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/D\"><num value=\"D\">(D)</num><content> Shortage of an inactive ingredient component.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086985-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/E\"><num value=\"E\">(E)</num><content> Discontinuance of the manufacture of the drug.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086986-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/F\"><num value=\"F\">(F)</num><content> Delay in shipping of the drug.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7d086987-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/3/G\"><num value=\"G\">(G)</num><content> Demand increase for the drug.</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7d086988-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/b/4\"><num value=\"4\">(4)</num><content> The estimated duration of the shortage as determined by the Secretary.</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7d086989-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/c\"><num value=\"c\" class=\"bold\">(c)</num><heading class=\"bold\"> Public availability</heading><paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id7d08698a-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/c/1\"><num value=\"1\" class=\"bold\">(1)</num><heading class=\"bold\"> In general</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">Subject to paragraphs (2) and (3), the Secretary shall make the information in such list publicly available.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id7d08698b-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/c/2\"><num value=\"2\" class=\"bold\">(2)</num><heading class=\"bold\"> Trade secrets and confidential information</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">Nothing in this section alters or amends <ref href=\"/us/usc/t18/s1905\">section 1905 of title 18</ref> or <ref href=\"/us/usc/t5/s552/b/4\">section 552(b)(4) of title 5</ref>.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id7d08698c-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/c/3\"><num value=\"3\" class=\"bold\">(3)</num><heading class=\"bold\"> Public health exception</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The Secretary may choose not to make information collected under this section publicly available under paragraph (1) or <ref href=\"/us/usc/t21/s356c/c\">section 356c(c) of this title</ref> if the Secretary determines that disclosure of such information would adversely affect the public health (such as by increasing the possibility of hoarding or other disruption of the availability of drug products to patients).</p>\n</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7d08698d-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s356e/d\"><num value=\"d\" class=\"bold\">(d)</num><heading class=\"bold\"> Interagency notification</heading><content><p style=\"-uslm-lc:I11\" class=\"indent0\">Not later than 180 days after <date date=\"2020-03-27\">March 27, 2020</date>, and every 90 days thereafter, the Secretary shall transmit a report regarding the drugs of the current drug shortage list under this section to the Administrator of the Centers for Medicare &amp; Medicaid Services.</p>\n</content>\n</subsection>\n<sourceCredit id=\"id7d08698e-81bc-11eb-b838-b6993269d559\">(<ref href=\"/us/act/1938-06-25/ch675/s506E\">June 25, 1938, ch. 675, § 506E</ref>, as added <ref href=\"/us/pl/112/144/tX/s1004\">Pub. L. 112–144, title X, § 1004</ref>, <date date=\"2012-07-09\">July 9, 2012</date>, <ref href=\"/us/stat/126/1104\">126 Stat. 1104</ref>; amended <ref href=\"/us/pl/114/255/dA/tIII/s3101/a/2/G\">Pub. L. 114–255, div. A, title III, § 3101(a)(2)(G)</ref>, <date date=\"2016-12-13\">Dec. 13, 2016</date>, <ref href=\"/us/stat/130/1153\">130 Stat. 1153</ref>; <ref href=\"/us/pl/116/136/dA/tIII/s3112/c\">Pub. L. 116–136, div. A, title III, § 3112(c)</ref>, <date date=\"2020-03-27\">Mar. 27, 2020</date>, <ref href=\"/us/stat/134/362\">134 Stat. 362</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"id7d08698f-81bc-11eb-b838-b6993269d559\">\n<note style=\"-uslm-lc:I74\" role=\"crossHeading\" topic=\"editorialNotes\" id=\"id7d086990-81bc-11eb-b838-b6993269d559\"><heading class=\"centered\"><b>Editorial Notes</b></heading></note>\n<note style=\"-uslm-lc:I74\" topic=\"amendments\" id=\"id7d086991-81bc-11eb-b838-b6993269d559\"><heading class=\"centered smallCaps\">Amendments</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">2020—Subsec. (d). <ref href=\"/us/pl/116/136\">Pub. L. 116–136</ref> added subsec. (d).</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">2016—Subsec. (b)(3)(E). <ref href=\"/us/pl/114/255\">Pub. L. 114–255</ref>, which directed substitution of “discontinuance” for “discontinuation”, was executed by substituting “Discontinuance” for “Discontinuation” to reflect the probable intent of Congress.</p>\n</note>\n<note style=\"-uslm-lc:I74\" role=\"crossHeading\" topic=\"statutoryNotes\" id=\"id7d0890a2-81bc-11eb-b838-b6993269d559\"><heading class=\"centered\"><b>Statutory Notes and Related Subsidiaries</b></heading></note>\n<note style=\"-uslm-lc:I74\" topic=\"effectiveDateOfAmendment\" id=\"id7d0890a3-81bc-11eb-b838-b6993269d559\"><heading class=\"centered smallCaps\">Effective Date of 2020 Amendment</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">Amendment by <ref href=\"/us/pl/116/136\">Pub. L. 116–136</ref> effective 180 days after <date date=\"2020-03-27\">Mar. 27, 2020</date>, see <ref href=\"/us/pl/116/136/s3112/g\">section 3112(g) of Pub. L. 116–136</ref>, set out as a note under <ref href=\"/us/usc/t21/s356c\">section 356c of this title</ref>.</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"117-185","currency_date":"2022-10-04","congress":117,"law_num":185,"excluded_laws":[],"update_num":null,"seq":286,"is_partial":false,"caveat":null,"titles_affected":["03","10","13","15","18","21","22","38","42","47","52"],"ingested_titles":[]},"served_from":{"label":"117-185","currency_date":"2022-10-04","congress":117,"law_num":185,"excluded_laws":[],"update_num":null,"seq":286,"is_partial":false,"caveat":null,"titles_affected":["03","10","13","15","18","21","22","38","42","47","52"],"ingested_titles":[]},"content_first_seen":{"label":"116-314not260not283","currency_date":"2021-01-05","congress":116,"law_num":314,"excluded_laws":[260,283],"update_num":null,"seq":225,"is_partial":true,"caveat":"Current through Public Law 116-314 (01/05/2021), except 116-260, 116-283.","titles_affected":["05","05a","06","15","16","18","21","25","28","31","33","34","42","50","54"],"ingested_titles":[]},"is_exact":true,"note":null}